Showing results (11-20 of 291) with videos related to

Sort By:
Pageof 30
Critical Reviews in Oncology/Hematology|October 19, 2021
The Impact of Pelvic Nodal Radiotherapy on Hematologic Toxicity: A Systematic Review with Focus on Leukopenia, Lymphopenia and Future Perspectives in Prostate Cancer TreatmentGiuseppe Carlo Iorio, Benjamin Oren Spieler, Umberto Ricardi, et al.
Investigative and Clinical Urology|September 13, 2016
Urethral strictures after radiation therapy for prostate cancerFelix Moltzahn, Alan Dal Pra, Marc Furrer, et al.
Thoracic Cancer|September 21, 2020
Impacts of post-radiotherapy lymphocyte count on progression-free and overall survival in patients with stage III lung cancerJuliana Matiello, Alan Dal Pra, Laise Zardo, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2017
Exosomes and Exosomal MicroRNAs in Prostate Cancer Radiation TherapyBijaya Malla, Kathrin Zaugg, Erik Vassella, et al.
Seminars in Radiation Oncology|June 14, 2025
Debate 3: Metastasis Directed Therapy in Oligometastatic Prostate CancerManeesh Singh, Vedang Murthy, Piet Ost
Clinical and Translational Radiation Oncology|August 22, 2025
Unmasking enteritis: reply to commentary titled "Clarifying Gastrointestinal toxicity attribution in WP-SBRT: A commentary on Dinesan et al. and proposal of a bladder-bowel displacement index"Akshay Dinesan, Maneesh Singh, Vedang Murthy
The Canadian Journal of Urology|August 13, 2013
New-onset psychosis following androgen deprivation therapy for prostate cancerDaniel M Bernad, Alan Dal Pra, Cintia Baule, et al.
Nature Reviews. Urology|March 25, 2015
Synergistic action of image-guided radiotherapy and androgen deprivation therapyJennifer A Locke, Alan Dal Pra, Stéphane Supiot, et al.
The British Journal of Radiology|August 14, 2020
Toxicity reduction required for MRI-guided radiotherapy to be cost-effective in the treatment of localized prostate cancerLeif-Erik D Schumacher, Alan Dal Pra, Sarah E Hoffe, et al.
Frontiers in Oncology|February 25, 2016
Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate CancerAlan Dal Pra, Jennifer A Locke, Gerben Borst, et al.
Pageof 30